Apigenin promotes neuronal norepinephrine release via GPR30/PLCβ1-Ca2+-Syt1 signaling to enhance astrocytic lactate and exert neuroprotection in D-galactose-induced cognitive impairment
Oct 2026· Frontiers in Pharmacology· 0 citations· 48 references
TL;DR
This study clarifies the PLCβ1-Ca 2+ -Syt1-dependent mechanism of Api in aging-related cognitive impairment, but also highlights NE and lactate elevation as a promising therapeutic approach.
Abstract
AD, a prevalent neurodegenerative disorder clinically defined by progressive cognitive impairment, is pathologically featured by early dysfunction of the locus coeruleus, depletion of noradrenergic (NE) neurons, and dysregulated astrocytic glycogen metabolism, which collectively compromise patients’ daily functioning. Although Api, a common phytoestrogen, has shown therapeutic efficacy in diverse diseases, its role and mechanism in AD remain unexplored.
To address this gap, we evaluated the protective effects of Api against D-gal-induced cognitive deficits through behavioral and histomorphological assessments. Untargeted metabolomics was performed to profile metabolic alterations in the locus coeruleus (LC), complemented by targeted metabolomics focusing on specific pathways. Putative targets were predicted by molecular docking and verified via cellular thermal shift assay (CETSA), while molecular biology approaches were adopted to elucidate the underlying signaling cascades.
Api significantly ameliorated D-gal-induced cognitive impairment and increased hippocampal NE and lactate levels with enhanced neuronal activity. Metabolomics indicated that Api regulates energy metabolism pathways including TCA cycle, amino acid metabolism, glycolysis/gluconeogenesis, and glutathione metabolism. Specifically, Api elevated NE and lactate in the LC. GPR30 was identified and validated as the key target via molecular docking and CETSA, showing strong binding affinity. Mechanistically, Api activates GPR30 on noradrenergic neurons to regulate PLCβ1-Ca
2+
-Syt1 signaling, promoting NE release, which in turn drives astrocytic glycogenolysis and lactate production, thereby relieving neuronal energy deficits.
Collectively, this study not only clarifies the PLCβ1-Ca
2+
-Syt1-dependent mechanism of Api in aging-related cognitive impairment, but also highlights NE and lactate elevation as a promising therapeutic approach.
ETHNOPHARMACOLOGICAL RELEVANCE
Dihydrocaffeic acid (DHCA) is a phenolic acid produced through the microbial metabolism of plant-derived caffeoylquinic acids. DHCA has been detected in human plasma following oral administration of a standardized aqueous extract of Centella asiatica (L.) Urb., a medicinal plant tradition...
Jia Shang, Yi-Wei Wang, Wei Wang et al.· Journal of Ethnopharmacology· 0 citations
INTRODUCTION
Major depressive disorder (MDD) is a neuropsychiatric disorder associated with abnormal neuronal activity in specific brain regions. Recent evidence suggests that oxidative stress- and neuroinflammation-driven impairments in synaptic structure and neuronal function may contribute to depression, yet the pre...
Yong-Si Zhao, Meng-Ni Chang, Cheng-Xin Hu et al.· Journal of Advanced Research· 0 citations
Results showed that isovitexin significantly extended lifespan, reduced Aβ accumulation, and improved neuromuscular function, demonstrating marked neuroprotective effects, and support further investigation of isovitexin as a candidate for mitigating Aβ-induced neurodegeneration.
Meng-Jiao Hao, Dong-Ni Wu, Ling-Li Sun et al.· Journal of Agricultural and...· 0 citations
Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, synaptic dysfunction, and neuronal injury. Cannabidiol (CBD), a non-psychoactive constituent of Cannabis sativa L., has neuroprotective potential, but its underlying mechanisms remain unclear. Purpose: T...
Yan-Xia Kong, Juan Peng, Jian Sun et al.· Biomolecules· 0 citations
ABSTRACT
Obesity is strongly associated with cognitive impairment, especially in memory. However, the underlying molecular mechanisms remain unclear. Ca2+/calmodulin-dependent protein kinase II (CaMKII), a key synaptic kinase, regulates synaptic plasticity and hippocampal memory function through N-methyl-D-aspartate re...
Fan Liu, Chen Chen, Yu-Bing Zeng et al.· Neural Regeneration Research· 0 citations
BACKGROUND
Neuroinflammation is a major contributor to cognitive dysfunction, yet the mechanisms linking inflammatory signaling to synaptic dysfunction remain incompletely understood. Kynurenic acid (KYNA), an endogenous metabolite derived from tryptophan catabolism, modulates neuronal and synaptic activity, yet its in...